Key Drivers
- Margin Expansion
- Strong Liquidity
- Leverage Concerns
AIAI Summary
NVST is becoming a cash-backed margin-recovery story, with modest sales growth expected to drive outsized EBITDA and EPS gains, but its elevated valuation leaves little tolerance for continued China and equipment-demand weakness; consider upside only if margins and free-cash-flow conversion persist while support near $23.35 holds.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Strong Liquidity
- •Leverage Concerns
NVST shows improving quarterly profitability and strong cash flow/liquidity, but high leverage, intangible-asset reliance, negative retained earnings, and elevated earnings multiples warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Oversold momentum
- •Critical support
NVST is in a bearish last-month downtrend with oversold rebound potential, but a break below $23.35 would raise downside risk while recovery above $24.70–$25.80 is needed to improve momentum.
Selling accelerated after 2026-09-14
Sentiment & News
Key News Insights:
- •Institutional Buying
- •Value Support
- •Recent Pullback
Envista remains a compelling value play with institutional buying and earnings support, though recent share weakness warrants caution.
Positive fundamentals may support NVST's recovery, but near-term volatility remains a risk
Similar Companies in Healthcare
Other companies in the same sector with AI ratings